Geode Capital Management
FMTX

Geode Capital Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Geode Capital Management’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-701,849
Closed -$14M – 5064
2022
Q3 		$14M Buy
701,849
+93,761
+15% +$1.24M ﹤0.01% 1999
2022
Q2 		$4.19M Buy
608,088
+43,776
+8% +$307K ﹤0.01% 2800
2022
Q1 		$5.25M Buy
564,312
+10,536
+2% +$112K ﹤0.01% 2771
2021
Q4 		$7.87M Buy
553,776
+61,407
+12% +$1.06M ﹤0.01% 2611
2021
Q3 		$11.4M Buy
492,369
+45,722
+10% +$1.08M ﹤0.01% 2365
2021
Q2 		$11.1M Buy
446,647
+13,360
+3% +$359K ﹤0.01% 2386
2021
Q1 		$12.1M Buy
433,287
+138,283
+47% +$4.99M ﹤0.01% 2231
2020
Q4 		$10.3M Buy
295,004
+35,165
+14% +$1.53M ﹤0.01% 2159
2020
Q3 		$12.9M Buy
259,839
+239,144
+1,156% +$9.67M ﹤0.01% 1800
2020
Q2 		$962K Buy
+20,695
New +$897K ﹤0.01% 3149

Geode Capital Management's FMTX Position: Q4 2022 in Review

Geode Capital Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 701,849 shares — an estimated $14M sold.

Geode Capital Management first reported a position in FMTX in Q2 2020 and held it in 10 quarters. The position peaked at $14M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Geode Capital Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Geode Capital Management sold 701,849 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $14M.
  • Geode Capital Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
  • Geode Capital Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $14M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Geode Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.